» Articles » PMID: 9550186

Demonstration of Potential Noninvasive Ultrasound Brain Therapy Through an Intact Skull

Overview
Specialty Radiology
Date 1998 Apr 29
PMID 9550186
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Utilization of therapeutic ultrasound in the brain has been seriously limited by the commonly accepted view that these exposures would require that a piece of the skull bone be removed to allow the ultrasound beam to propagate into the brain. In this paper, the feasibility of delivering ultrasound therapy through the intact skull was studied. Sonications were performed through a piece of human skull with focused transducers at 0.248, 0.559, 1.0 and 1.68 MHz. The skull attenuated and distorted the field; however, a sharp focal spot was created at frequencies of 1 MHz or lower. At the higher frequency, the focus was destroyed. To investigate the feasibility of compensating for the ultrasound field distortion caused by the bone, phased array experiments were performed. Two arrays with 64 elements, operating at 0.6 MHz and 1.58 MHz, were used in these experiments. The phase shifts caused by the skull were measured for each element of the arrays and then compensated for by phase-control circuitry. These phase corrections allowed a sharp focus to be generated at both frequencies. Finally, tissue destruction was induced by using pulsed sonication through a piece of human skull in a rabbit brain in vivo at the frequency of 0.559 MHz. In summary, the results showed that transcranial delivery of therapeutic ultrasound into the brain may be feasible.

Citing Articles

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.

PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.


Preliminary Examination of the Effects of Focused Ultrasound on Living Skin and Temperature at the Skin-Transducer Interface.

Bishay A, Swenson A, Spivak N, Schafer S, Bych B, Gilles S Bioengineering (Basel). 2024; 11(11).

PMID: 39593786 PMC: 11591555. DOI: 10.3390/bioengineering11111126.


What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?.

Fujimoto S, Fujimoto A, Elorette C, Choi K, Mayberg H, Russ B Neuropsychopharmacology. 2024; 50(1):184-195.

PMID: 39198580 PMC: 11526173. DOI: 10.1038/s41386-024-01976-2.


H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions.

Nonnenbroich L, Bouchal S, Millesi E, Rechberger J, Khatua S, Daniels D Cells. 2024; 13(13.

PMID: 38994974 PMC: 11240752. DOI: 10.3390/cells13131122.


Beyond silence: evolving ultrasound strategies in the battle against cardiovascular thrombotic challenges.

Wang Z, Jiang N, Jiang Z, Deng Q, Zhou Q, Hu B J Thromb Thrombolysis. 2024; 57(6):1040-1050.

PMID: 38689069 DOI: 10.1007/s11239-024-02989-w.